8-K/A XBRL

FORM 8-K/A

Company: Axsome Therapeutics, Inc.
Filed: September 22, 2020
Period of Report: September 21, 2020
Accession Number: 0001104659-20-107108

View Document ↗ View on SEC.gov ↗